High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 2025-2034

  Duncan, Christopher J A ^a   Williams, James P ^b   Schiffner, Torben ^a   Gärtner, Kathleen ^b   Ochsenbauer, Christina ^c   Kappes, John ^c   Russell, Rebecca A ^a   Frater, John ^b   Sattentau, Quentin J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; IMMUNE EVASION; IMMUNOLOGICAL SYNAPSES; INTERCELLULAR ADHESION MOLECULE-1; LUCIFERASES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGES; MICROSCOPY, CONFOCAL; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; TIME-LAPSE IMAGING;

EID: 84893519255     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03245-13     Document Type: Article

References (62)

1. Zalar A, Figueroa MI, Ruibal-Ares B, Bare P, Cahn P, de Bracco MM, Belmonte L. 2010. Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART. Antiviral Res. 87:269-271. http://dx.doi.org/10.1016/j.antiviral.2010.05.005.
2. Gavegnano C, Schinazi RF. 2009. Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir. Chem. Chemother. 20:63-78. http://dx.doi.org/10.3851/IMP1374.
3. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. 2007. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177:329-341. http://dx.doi.org/10.1083/jcb.200609050.
4. Groot F, Welsch S, Sattentau QJ. 2008. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 111:4660-4663. http://dx.doi.org/10.1182/blood-2007-12-130070.
5. Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, Lowekamp BC, Yoo TS, Bliss D, Freed EO, Subramaniam S. 2009. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog. 5:e1000591. http://dx.doi.org/10.1371/journal.ppat.1000591.
6. Welsch S, Groot F, Krausslich HG, Keppler OT, Sattentau QJ. 2011. Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J. Virol. 85:7922-7927. http://dx.doi.org/10.1128/JVI.00834-11.
7. Koppensteiner H, Banning C, Schneider C, Hohenberg H, Schindler M. 2012. Macrophage internal HIV-1 is protected from neutralizing antibodies. J. Virol. 86:2826-2836. http://dx.doi.org/10.1128/JVI.05915-11.
8. Chu H, Wang JJ, Qi M, Yoon JJ, Wen X, Chen X, Ding L, Spearman P. 2012. The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules. PLoS One 7:e35297. http://dx.doi.org/10.1371/journal.pone.0035297.
9. Sharova N, Swingler C, Sharkey M, Stevenson M. 2005. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24:2481-2489. http://dx.doi.org/10.1038/sj.emboj.7600707.
10. Aggarwal A, McAllery S, Turville SG. 2013. Revising the role of myeloid cells in HIV pathogenesis. Curr. HIV/AIDS Rep. 10:3-11. http://dx.doi.org/10.1007/s11904-012-0149-1.
11. Koppensteiner H, Brack-Werner R, Schindler M. 2012. Macrophages and their relevance in human immunodeficiency virus type I infection. Retrovirology 9:82. http://dx.doi.org/10.1186/1742-4690-9-82.
12. Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, Ott DE, Freed EO. 2008. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 4:e1000015. http://dx.doi.org/10.1371/journal.ppat.1000015.
13. Waki K, Freed EO. 2010. Macrophages and cell-cell spread of HIV-1. Viruses 2:1603-1620. http://dx.doi.org/10.3390/v2081603.
14. Sattentau QJ. 2010. Cell-to-cell spread of retroviruses. Viruses 2:1306-1321. http://dx.doi.org/10.3390/v2061306.
15. Murooka TT, Deruaz M, Marangoni F, Vrbanac VD, Seung E, von Andrian UH, Tager AM, Luster AD, Mempel TR. 2012. HIV-infected T cells are migratory vehicles for viral dissemination. Nature 490:283-287. http://dx.doi.org/10.1038/nature11398.
16. Sewald X, Gonzalez DG, Haberman AM, Mothes W. 2012. In vivo imaging of virological synapses. Nat. Commun. 3:1320. http://dx.doi.org/10.1038/ncomms2338.
17. Carr JM, Hocking H, Li P, Burrell CJ. 1999. Rapid and efficient cell-tocell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265:319-329. http://dx.doi.org/10.1006/viro.1999.0047.
18. Duncan CJ, Russell RA, Sattentau QJ. 2013. High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy. AIDS 27:2201-2206. http://dx.doi.org/10.1097/QAD.0b013e3283632ec4.
19. Mann DL, Gartner S, Le Sane F, Buchow H, Popovic M. 1990. HIV-1 transmission and function of virus-infected monocytes/macrophages. J. Immunol. 144:2152-2158.
20. Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. 2010. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J. Virol. 84:3516-3527. http://dx.doi.org/10.1128/JVI.02651-09.
21. Schiffner T, Sattentau QJ, Duncan CJ. 2013. Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies. Vaccine 31:5789-5797. http://dx.doi.org/10.1016/j.vaccine.2013.10.020.
22. Burton DR, Poignard P, Stanfield RL, Wilson IA. 2012. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337:183-186. http://dx.doi.org/10.1126/science.1225416.
23. Kwong PD, Mascola JR, Nabel GJ. 2013. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat. Rev. Immunol. 13:693-701. http://dx.doi.org/10.1038/nri3516.
24. Mouquet H, Nussenzweig MC. 2013. HIV: roadmaps to a vaccine. Nature 496:441-442. http://dx.doi.org/10.1038/nature12091.
25. Huang KH, Bonsall D, Katzourakis A, Thomson EC, Fidler SJ, Main J, Muir D, Weber JN, Frater AJ, Phillips RE, Pybus OG, Goulder PJ, McClure MO, Cooke GS, Klenerman P. 2010. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat. Commun. 1:102. http://dx.doi.org/10.1038/ncomms1100.
26. Martin N, Sattentau Q. 2009. Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr. Opin. HIV AIDS 4:143-149. http://dx.doi.org/10.1097/COH.0b013e328322f94a.
27. Abela IA, Berlinger L, Schanz M, Reynell L, Gunthard HF, Rusert P, Trkola A. 2012. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog. 8:e1002634. http://dx.doi.org/10.1371/journal.ppat.1002634.
28. Durham ND, Yewdall AW, Chen P, Lee R, Zony C, Robinson JE, Chen BK. 2012. Neutralization resistance of HIV-1 virological synapsemediated infection is regulated by the gp41 cytoplasmic tail. J. Virol. 86: 7484-7495. http://dx.doi.org/10.1128/JVI.00230-12.
29. Chen P, Hubner W, Spinelli MA, Chen BK. 2007. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81:12582-12595. http://dx.doi.org/10.1128/JVI.00381-07.
30. Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, Montefiori DC, Kappes JC, Ochsenbauer C. 2010. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology 408:1-13. http://dx.doi.org/10.1016/j.virol.2010.08.028.
31. Carter GC, Bernstone L, Baskaran D, James W. 2011. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 409:234-250. http://dx.doi.org/10.1016/j.virol.2010.10.018.
32. Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H. 2008. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329:112-124. http://dx.doi.org/10.1016/j.jim.2007.09.017.
33. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O. 2007. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 81:1000-1012. http://dx.doi.org/10.1128/JVI.01629-06.
34. Mexas AM, Graf EH, Pace MJ, Yu JJ, Papasavvas E, Azzoni L, Busch MP, Di Mascio M, Foulkes AS, Migueles SA, Montaner LJ, O'Doherty U. 2012. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials. AIDS 26:2295-2306. http://dx.doi.org/10.1097/QAD.0b013e32835a5c2f.
35. Agosto LM, Yu JJ, Dai J, Kaletsky R, Monie D, O'Doherty U. 2007. HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology368:60-72. http://dx.doi.org/10.1016/j.virol.2007.06.001.
36. Liszewski MK, Yu JJ, O'Doherty U. 2009. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 47:254-260. http://dx.doi.org/10.1016/j.ymeth.2009.01.002.
37. Vasiliver-Shamis G, Dustin ML, Hioe CE. 2010. HIV-1 virological synapse is not simply a copycat of the immunological synapse. Viruses 2:1239-1260. http://dx.doi.org/10.3390/v2051239.
38. Tan J, Sattentau QJ. 2013. The HIV-1-containing macrophage compart-ment: a perfect cellular niche? Trends Microbiol. 21:405-412. http://dx.doi.org/10.1016/j.tim.2013.05.001.
39. Berre S, Gaudin R, Cunha de Alencar B, Desdouits M, Chabaud M, Naffakh N, Rabaza-Gairi M, Gobert FX, Jouve M, Benaroch P. 2013. CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells. J. Exp. Med. 210:2523-2538. http://dx.doi.org/10.1084/jem.20130566.
40. Mlcochova P, Pelchen-Matthews A, Marsh M. 2013. Organization and regulation of intracellular plasma membrane-connected HIV-1 assembly compartments in macrophages. BMC Biol. 11:89. http://dx.doi.org/10.1186/1741-7007-11-89.
41. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199:283-293. http://dx.doi.org/10.1084/jem.20030648.
42. Jolly C, Mitar I, Sattentau QJ. 2007. Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J. Virol. 81:13916-13921. http://dx.doi.org/10.1128/JVI.01585-07.
43. Rodriguez-Plata MT, Puigdomenech I, Izquierdo-Useros N, Puertas MC, Carrillo J, Erkizia I, Clotet B, Blanco J, Martinez-Picado J. 2013. The infectious synapse formed between mature dendritic cells and CD4+ T cells is independent of the presence of the HIV-1 envelope glycoprotein. Retrovirology 10:42. http://dx.doi.org/10.1186/1742-4690-10-42.
44. Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR. 2010. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 84: 1439-1452. http://dx.doi.org/10.1128/JVI.02108-09.
45. Sagar M, Akiyama H, Etemad B, Ramirez N, Freitas I, Gummuluru S. 2012. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection. J. Infect. Dis. 205:1248-1257. http://dx.doi.org/10.1093/infdis/jis183.
46. Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D. 2011. Cell-to-cell spread ofHIVpermits ongoing replication despite antiretroviral therapy. Nature 477:95-98. http://dx.doi.org/10.1038/nature10347.
47. Sigal A, Baltimore D. 2012. As good as it gets? The problem of HIV persistence despite antiretroviral drugs. Cell Host Microbe 12:132-138. http://dx.doi.org/10.1016/j.chom.2012.07.005.
48. Jolly C, Booth NJ, Neil SJ. 2010. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J. Virol. 84:12185-12199. http://dx.doi.org/10.1128/JVI.01447-10.
49. Cory TJ, Schacker TW, Stevenson M, Fletcher CV. 2013. Overcoming pharmacologic sanctuaries. Curr. Opin. HIV AIDS 8:190-195. http://dx.doi.org/10.1097/COH.0b013e32835fc68a.
50. Del Portillo A, Tripodi J, Najfeld V, Wodarz D, Levy DN, Chen BK. 2011. Multiploid inheritance of HIV-1 during cell-to-cell infection. J. Virol. 85:7169-7176. http://dx.doi.org/10.1128/JVI.00231-11.
51. Russell RA, Martin N, Mitar I, Jones E, Sattentau QJ. 2013. Multiple proviral integration events after virological synapse-mediated HIV-1 spread. Virology 443:143-149. http://dx.doi.org/10.1016/j.virol.2013.05.005.
52. Jolly C, Welsch S, Michor S, Sattentau QJ. 2011. The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog. 7:e1002226. http://dx.doi.org/10.1371/journal.ppat.1002226.
53. Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, Jouve M, Benaroch P. 2013. Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections. PLoS One 8:e69450. http://dx.doi.org/10.1371/journal.pone.0069450.
54. Choudhry V, Zhang MY, Harris I, Sidorov IA, Vu B, Dimitrov AS, Fouts T, Dimitrov DS. 2006. Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration. Biochem. Biophys. Res. Commun. 348:1107-1115. http://dx.doi.org/10.1016/j.bbrc.2006.07.163.
55. Su B, Xu K, Lederle A, Peressin M, Biedma ME, Laumond G, Schmidt S, Decoville T, Proust A, Lambotin M, Holl V, Moog C. 2012. Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T-lymphocytes. Blood 120:3708-3717. http://dx.doi.org/10.1182/blood-2012-03-418913.
56. Dale BM, McNerney GP, Thompson DL, Hubner W, de Los Reyes K, Chuang FY, Huser T, Chen BK. 2011. Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion. Cell Host Microbe 10:551-562. http://dx.doi.org/10.1016/j.chom.2011.10.015.
57. Kong L, Lee JH, Doores KJ, Murin CD, Julien JP, McBride R, Liu Y, Marozsan A, Cupo A, Klasse PJ, Hoffenberg S, Caulfield M, King CR, Hua Y, Le KM, Khayat R, Deller MC, Clayton T, Tien H, Feizi T, Sanders RW, Paulson JC, Moore JP, Stanfield RL, Burton DR, Ward AB, Wilson IA. 2013. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat. Struct. Mol. Biol. 20:796-803. http://dx.doi.org/10.1038/nsmb.2594.
58. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC. 2012. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86:2715-2728. http://dx.doi.org/10.1128/JVI.06157-11.
59. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206:1273-1289. http://dx.doi.org/10.1084/jem.20090378.
60. Liedtke S, Adamski M, Geyer R, Pfutzner A, Rubsamen-Waigmann H, Geyer H. 1994. Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. Glycobiology 4:477-484. http://dx.doi.org/10.1093/glycob/4.4.477.
61. Willey RL, Shibata R, Freed EO, Cho MW, Martin MA. 1996. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T lymphocyte and macrophage cultures. J. Virol. 70:6431-6436.
62. Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, Mouquet H, Spatz LA, Diskin R, Abadir A, Zang T, Dorner M, Billerbeck E, Labitt RN, Gaebler C, Marcovecchio PM, Incesu RB, Eisenreich TR, Bieniasz PD, Seaman MS, Bjorkman PJ, Ravetch JV, Ploss A, Nussenzweig MC. 2012. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 492:118-122. http://dx.doi.org/10.1038/nature11604.